Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

UroGen Pharma (URGN) Inventory Average: 2017-2025

Historic Inventory Average for UroGen Pharma (URGN) over the last 5 years, with Sep 2025 value amounting to $7.7 million.

  • UroGen Pharma's Inventory Average rose 2.88% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 2.88%. This contributed to the annual value of $7.5 million for FY2024, which is 49.03% up from last year.
  • UroGen Pharma's Inventory Average amounted to $7.7 million in Q3 2025, which was up 5.10% from $7.4 million recorded in Q2 2025.
  • UroGen Pharma's Inventory Average's 5-year high stood at $8.4 million during Q4 2024, with a 5-year trough of $2.6 million in Q1 2021.
  • For the 3-year period, UroGen Pharma's Inventory Average averaged around $6.7 million, with its median value being $7.3 million (2024).
  • Data for UroGen Pharma's Inventory Average shows a peak YoY spiked of 192.55% (in 2021) over the last 5 years.
  • Over the past 5 years, UroGen Pharma's Inventory Average (Quarterly) stood at $4.3 million in 2021, then climbed by 6.33% to $4.6 million in 2022, then grew by 16.20% to $5.3 million in 2023, then spiked by 57.57% to $8.4 million in 2024, then rose by 2.88% to $7.7 million in 2025.
  • Its Inventory Average was $7.7 million in Q3 2025, compared to $7.4 million in Q2 2025 and $8.4 million in Q1 2025.